LIVZON PHARMA (01513) has accumulated repurchased 9.426 million shares of A shares.
Lizhu Pharmaceutical (01513) announced that as of February 28, 2025, the company has completed the centralized auction trading...
LIVZON PHARMA (01513) announced that as of February 28, 2025, the company repurchased a total of 9.426 million A shares through centralized bidding trading, accounting for 1.03% of the total share capital. The highest purchase price was RMB 38.37 per share, the lowest price was RMB 35.18 per share, and the total amount of funds used was RMB 342 million (excluding transaction costs). The repurchase mentioned above complies with the company's established share repurchase program.
Related Articles
Hainan Haiyao (000566.SZ): Cefoperazone sodium for injection passes consistency evaluation.
Shanghai Pharmaceuticals Holding (02607) released a profit announcement: it is expected that the net profit attributable to the parent company for the first half of the year will be 4.45 billion yuan, an increase of around 52% year-on-year.
Guotai Haitong (02611) has repurchased a total of 67,516,800 A-shares.
Hainan Haiyao (000566.SZ): Cefoperazone sodium for injection passes consistency evaluation.
Shanghai Pharmaceuticals Holding (02607) released a profit announcement: it is expected that the net profit attributable to the parent company for the first half of the year will be 4.45 billion yuan, an increase of around 52% year-on-year.
Guotai Haitong (02611) has repurchased a total of 67,516,800 A-shares.
RECOMMEND
